{"id":204111,"date":"2026-01-13T15:01:59","date_gmt":"2026-01-13T14:01:59","guid":{"rendered":"https:\/\/efecomunica.efe.com\/?p=204111"},"modified":"2026-01-13T16:55:26","modified_gmt":"2026-01-13T15:55:26","slug":"citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization","status":"publish","type":"post","link":"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/","title":{"rendered":"Citeline-Risklick partnership creates smarter protocols, from design to optimization"},"content":{"rendered":"<p>Statement issued by the company (Announcement)<\/p>\n<h2>Citeline\u2019s Best-in-Class Data and AI Combine with Risklick\u2019s End-to-End Digital Protocol Workflow<\/h2>\n<div>\n<p><strong>Citeline<\/strong>, a leader in clinical solutions for the life sciences industry, and <strong>Risklick<\/strong>, a Swiss-based company specializing in <strong>AI-driven solutions<\/strong> for clinical trial protocol development, have partnered to develop a holistic solution that spans protocol design and authoring, operationalization and regulatory disclosure.<\/p>\n<p>Industry studies reveal that protocol amendments have risen substantially since 2015. Given that a single protocol amendment can cost between $140,000 and $500,000, sponsors are under pressure to design near-foolproof protocols.<\/p>\n<p>Together, <strong>Risklick<\/strong> and <strong>Citeline<\/strong> deliver an integrated, intelligent protocol development experience that combines smart authoring with AI-powered optimization, directly in the workflow.\u200b The result is optimally designed, patient-centered protocols that reduce risk, accelerate timelines and improve enrollment outcomes.\u200b<\/p>\n<p>With deep expertise in protocol component design\u200b, Citeline leverages its robust data and AI for evidence-based optimization of <strong>protocol endpoints and inclusion\/exclusion (I\/E) criteria<\/strong>\u200b. In addition, its AI models \u2014 drawing from successful trials, biomarkers, real-world patient data, and proprietary sponsor data \u2014 fine-tune operational forecasting and planning\u200b.<\/p>\n<p>\u201cBy embedding our best-in-class data directly into a digitized workflow, we are transforming protocol design from a manual hurdle into a high-speed, AI-driven engine that allows sponsors to move from concept to execution faster than ever before,\u201d says <strong>Suzanne Caruso<\/strong>, General Manager, Citeline Strategic Intelligence, Clinical &amp; Regulatory.<\/p>\n<p>Risklick, bringing to the table extensive protocol design and authoring workflow expertise and a purpose-built AI platform, \u200bhas digitized the entire protocol development process. Its \u200bAI assistant focuses on early clinical trial design and literature analysis, based on a user-defined knowledge base\u200b.<\/p>\n<p>&#8220;Our mission is to enable the pharmaceutical industry to design a clinical study in<strong>\u00a0<\/strong>just one day,\u201d says Dr. <strong>Poorya Amini<\/strong>, Founder &amp; CEO, Risklick.\u00a0\u201cThis partnership with Citeline is a key step toward making that vision a reality, by bringing together an interoperable solution that spans protocol design, operationalization and regulatory disclosure to create a fully connected digital trial ecosystem.&#8221;<\/p>\n<p>The two companies are digitally transforming protocol development and enhancing data-driven clinical trial design and operations. Their solution combines insights and workflow to improve protocol quality, empowering sponsors to build more predictable trials.\u200b<\/p>\n<h2>About Citeline<\/h2>\n<p>Citeline, a <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sj7aZlZuu5FKUckybxOsfEYi50B8E0GNmNpqQMExxqFWTa48RS4IQ1g58j6X1TYgQvHkjIC3q0OYh6DLrIO9sQ==\" target=\"_blank\" rel=\"noopener\">Norstella<\/a> company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory-related decisions and create real-world opportunities for growth.<\/p>\n<p>Citeline\u2019s global teams of analysts, journalists, and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering all with expert insights: key diseases, clinical trials, drug R&amp;D and approvals, market forecasts, and more. For more information on one of the world\u2019s most trusted health science partners, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=B9FNW8sTWkSB8oPkGmCo4YiMv-btIewj26QjDLxk12kaag2Gab6RoXtI35Q8fXhE7RuCzs4Hl3U6SpdYWTf1Uw==\" target=\"_blank\" rel=\"noopener\"><u>Citeline<\/u><\/a> and follow on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9LAVKWs2gRNCvlaXRdpg1xBtMNQgzjGH5gXSM9rN9LiDz3vAOm-Rxxt-Uz7HeEGZWBcVcWS988jZioFDjpJrNr7ip_PETYSC8ngQB1kfrIw=\" target=\"_blank\" rel=\"noopener\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6rg8gBzB8mAQa5K_JK3H-0gIIPeRt4suf-vc-R_1wwV0eFppG-m71r3QW1nVcSNGLulHLZiHi1-NswdWdEqfdw==\" target=\"_blank\" rel=\"noopener\">X<\/a> (Twitter).<\/p>\n<h2>About Risklick<\/h2>\n<p>Risklick is a Swiss-based company specializing in AI-driven solutions for clinical trial protocol development. The company partners with global pharmaceutical and biotech organizations to accelerate innovation by providing advanced tools for protocol design, data-driven study planning, and operational efficiency. Risklick\u2019s flagship platform, Protocol AI\u2122, empowers clinical teams to streamline processes and bring new therapies to patients faster. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xPCwdJmiu28jtvhj_R20bOuXR20IvV3HjqFh8ZJxD837vRh-8ZDXCWVqOeNxAM0jifef-aAtG2GPrl8kPpsvYA==\" target=\"_blank\" rel=\"noopener\">Risklick<\/a> and follow on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9LAVKWs2gRNCvlaXRdpg16gfxM8Ttw6QbvnvWB8XYplWmmqlIYkJ6L76EjmR-av5KjqvekAW-k4H8_r36TmwCvz5brd-oBEWSmnaJiB-ci8=\" target=\"_blank\" rel=\"noopener\">LinkedIn<\/a>.<\/p>\n<pre><strong>Citeline PR contact:<\/strong>\u00a0\r\nDiffusion PR for Citeline\r\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JZTzp6xO5TJWIhvm-ui-QJPQ1l4GF-Xxv7oyw8Z4qoeoe_boDz6IckSGbwPVWSrMWwbOp9jOm9PN9cDNlhbavKHk1hSvL3RxEa0DEeXvZ7MeAoxLXDmoY4aYsx7U-z-r\" target=\"_blank\" rel=\"noopener\"><u>citeline@diffusionpr.com<\/u><\/a>\u00a0\r\n(213) 318-4500<\/pre>\n<p>Photos accompanying this announcement are available at<\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=te-o3q-hZYBJp4cSFc8oOQLDJrQovmZl7xY4t1PkdRbckjXaYCdbwcTw_UgURmcvzpusnmgBFKsgnAP5OLItZZi-uLDT1-qnuVL7vC6F1xapvdd5sXx1z22xjUT4mE6pPkhK4sruMD2z5BO5nwIdaP1PCfP9Aeb7QaIJ5uyeKw_AawFj6FYLqZZIe02AqDeKBMRyzeO19AdObOMy4YEF9jyhjkQga3IbwUVfTyitclx00cR3p3tg0sY5OTIrJq9HhEEeW0ddOoNa5tsfCBQOKA==\" target=\"_blank\" rel=\"noopener\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/b77ff161-d84c-46f2-a2d3-abaf9e187dbd<\/a><\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=te-o3q-hZYBJp4cSFc8oOQLDJrQovmZl7xY4t1PkdRbckjXaYCdbwcTw_UgURmcvwJ6SdN0QOJMTPDgDKT19hN4FTr47PfHJnqVVPT77VIEYUP27W-eTZUfaUNcneqkpb77OGQQgPGWxIs6wMvz8rPWwxUfXCFNzNNwgdy4-5NOAa3QDB4S7lkk4o-IwoRhFin8Vezo6WPiUO3E2TE1ahOwlfzhi_0AXG90P6DxtZnuS_veP-OFf1HNdvBDksdYm_P_3VW10ZS70ADV1OIXfjw==\" target=\"_blank\" rel=\"noopener\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/590b144d-7883-4a17-b869-c52715219df3<\/a><\/p>\n<p><em>AGENCIA EFE S.A.U.,S.M.E. shall not be liable for any information contained in this message and assumes no responsibility towards third parties in relation to its contents, being expressly exempt from any liability that the author may have in relation to the information in question. Agencia EFE reserves the right to distribute the press release on the news wire, or to publish it on EFE Comunica.<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Statement issued by the company (Announcement) Citeline\u2019s Best-in-Class Data and AI Combine with Risklick\u2019s End-to-End Digital Protocol Workflow Citeline, a leader in clinical solutions for the life sciences industry, and [&hellip;]<\/p>\n","protected":false},"author":198164071,"featured_media":48434,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[125518],"tags":[],"class_list":["post-204111","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Citeline-Risklick partnership creates smarter protocols<\/title>\n<meta name=\"description\" content=\"Citeline has partnered to develop a solution that spans protocol design and authoring, operationalization and regulatory disclosure.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Citeline-Risklick partnership creates smarter protocols","description":"Citeline has partnered to develop a solution that spans protocol design and authoring, operationalization and regulatory disclosure.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/#article","isPartOf":{"@id":"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/"},"author":{"name":"EFE","@id":"https:\/\/efecomunica.efe.com\/#\/schema\/person\/38c335f1ce4cd42430576ef5499343b8"},"headline":"Citeline-Risklick partnership creates smarter protocols, from design to optimization","datePublished":"2026-01-13T14:01:59+00:00","dateModified":"2026-01-13T15:55:26+00:00","mainEntityOfPage":{"@id":"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/"},"wordCount":667,"publisher":{"@id":"https:\/\/efecomunica.efe.com\/#organization"},"image":{"@id":"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/#primaryimage"},"thumbnailUrl":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2022\/10\/Notified-GlobeNewswire-Color-Large-1.jpg","articleSection":["Globenewswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/","url":"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/","name":"Citeline-Risklick partnership creates smarter protocols","isPartOf":{"@id":"https:\/\/efecomunica.efe.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/#primaryimage"},"image":{"@id":"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/#primaryimage"},"thumbnailUrl":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2022\/10\/Notified-GlobeNewswire-Color-Large-1.jpg","datePublished":"2026-01-13T14:01:59+00:00","dateModified":"2026-01-13T15:55:26+00:00","description":"Citeline has partnered to develop a solution that spans protocol design and authoring, operationalization and regulatory disclosure.","breadcrumb":{"@id":"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/#primaryimage","url":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2022\/10\/Notified-GlobeNewswire-Color-Large-1.jpg","contentUrl":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2022\/10\/Notified-GlobeNewswire-Color-Large-1.jpg","width":1200,"height":650,"caption":"El \u00edndice Moneyball de Squawka clasifica a los clubes de la Premier League tomando en cuenta las \u00faltimas cinco temporadas (incluida la 2025\/26)."},{"@type":"BreadcrumbList","@id":"https:\/\/efecomunica.efe.com\/en\/citeline-risklick-partnership-creates-smarter-protocols-from-design-to-optimization\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/efecomunica.efe.com\/"},{"@type":"ListItem","position":2,"name":"Citeline-Risklick partnership creates smarter protocols, from design to optimization"}]},{"@type":"WebSite","@id":"https:\/\/efecomunica.efe.com\/#website","url":"https:\/\/efecomunica.efe.com\/","name":"EFE Comunica","description":"Contenidos para empresas","publisher":{"@id":"https:\/\/efecomunica.efe.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/efecomunica.efe.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/efecomunica.efe.com\/#organization","name":"EFE Comunica","url":"https:\/\/efecomunica.efe.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/efecomunica.efe.com\/#\/schema\/logo\/image\/","url":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2020\/12\/Logo-EFE-Comunica_png.png","contentUrl":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2020\/12\/Logo-EFE-Comunica_png.png","width":1080,"height":486,"caption":"EFE Comunica"},"image":{"@id":"https:\/\/efecomunica.efe.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/EFEComunicaAgenciaEFE","https:\/\/x.com\/EFEcomunica","https:\/\/www.linkedin.com\/showcase\/efecomunica"]},{"@type":"Person","@id":"https:\/\/efecomunica.efe.com\/#\/schema\/person\/38c335f1ce4cd42430576ef5499343b8","name":"EFE","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e5fcf26bedbd04dc20896c519164a13fe69c6913f5830d7db51543fa04eb30b4?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e5fcf26bedbd04dc20896c519164a13fe69c6913f5830d7db51543fa04eb30b4?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e5fcf26bedbd04dc20896c519164a13fe69c6913f5830d7db51543fa04eb30b4?s=96&d=identicon&r=g","caption":"EFE"},"sameAs":["http:\/\/efe.com"],"url":"https:\/\/efecomunica.efe.com\/en\/author\/efedesarrollo\/"}]}},"jetpack_featured_media_url":"https:\/\/efecomunica.efe.com\/wp-content\/uploads\/2022\/10\/Notified-GlobeNewswire-Color-Large-1.jpg","jetpack_likes_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pcEg1r-R67","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/posts\/204111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/users\/198164071"}],"replies":[{"embeddable":true,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/comments?post=204111"}],"version-history":[{"count":3,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/posts\/204111\/revisions"}],"predecessor-version":[{"id":204177,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/posts\/204111\/revisions\/204177"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/media\/48434"}],"wp:attachment":[{"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/media?parent=204111"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/categories?post=204111"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/efecomunica.efe.com\/en\/wp-json\/wp\/v2\/tags?post=204111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}